Home › Diabete › New York › New York City
Studi clinici su Diabete a New York City, NY
17 studi su Diabete cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
In reclutamentoFase 3
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
In reclutamentoFase 1/2
- Hassenfield Children's Hospital, New York
- NYU Langone Diabetes & Endocrine Associates, New York
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
In reclutamentoFase 3
- Kailera Clinical Site, New York
APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
In reclutamento
- Weill Cornell Medicine, New York
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
In reclutamentoFase 2
- Columbia University Irving Medical Center, New York
- Icahn School of Medicine at Mount Sinai, New York
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
In reclutamentoFase 4
- Columbia University Irving Medical Center, New York
ED Diabetes Screening and Outpatient Care - Aim 3
In reclutamento
- NYU Langone Health, New York
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
In reclutamento
- Maternal-Fetal Medicine at NYU Langone Obstetrics & Gynecology Associates, New York
A Study of a Weight Loss Intervention in People With Endometrial Cancer
In reclutamentoFase 1 iniziale
- Memorial Sloan Kettering Cancer Center, New York
CHIME: Comparing Health Interventions for Maternal Equity
In reclutamentoVolontari sani benvenuti
- Columbia University Medical Center, New York
- NYU Langone Health, New York
Transformative Research in Diabetic Nephropathy
In reclutamentoStudio osservazionale
- Mount Sinai Hospital, New York
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
In reclutamentoFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
In reclutamentoStudio osservazionale
- Columbia University Cystic Fibrosis Program, New York
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Columbia University Medical Center, New York
- Virtual Site (Remote enrollment), New York
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
In reclutamentoFase 1
- Columbia University Irving Medical Center, New York
Rare and Atypical Diabetes Network
In reclutamentoStudio osservazionale
- Columbia University, New York
NYSCF Scientific Discovery Biobank
In reclutamentoStudio osservazionale
- New York Stem Cell Foundation Research Institute, New York
Studi su Diabete in altre città
- Boston, MA23 studi
- Houston, TX16 studi
- Chicago, IL15 studi
- Durham, NC14 studi
- Aurora, CO14 studi
- Baltimore, MD13 studi
- Philadelphia, PA12 studi
- San Diego, CA10 studi
- Los Angeles, CA10 studi
- Indianapolis, IN10 studi
- Washington, DC10 studi
- Minneapolis, MN9 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.